4//SEC Filing
Goldan Keith A. 4
Accession 0001562180-22-005117
CIK 0001395937other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 4:12 PM ET
Size
7.4 KB
Accession
0001562180-22-005117
Insider Transaction Report
Form 4
Goldan Keith A.
Chief Financial Officer
Transactions
- Award
Common Stock
2022-06-13+3,205→ 3,205 total - Award
Stock Options (Right to buy)
2022-06-13$15.60/sh+230,000$3,588,000→ 230,000 totalExercise: $15.60Exp: 2032-06-13→ Common Stock (230,000 underlying)
Footnotes (2)
- [F1]Award of Restricted Stock Units that vest 50% of the shares on June 13, 2023 and the remaining 50% of the shares on June 13, 2024.
- [F2]Twenty five percent (25%) of the total number of shares underlying the option shall vest on June 13, 2023, and one-thirty-sixth (1/36th) of the remaining shares underlying the option shall vest monthly thereafter on the last day of each month, subject to the reporting person's continuous service on the relevant vesting dates.
Documents
Issuer
Syndax Pharmaceuticals Inc
CIK 0001395937
Entity typeother
Related Parties
1- filerCIK 0001495411
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 4:12 PM ET
- Size
- 7.4 KB